dc.contributor
Institut Català de la Salut
dc.contributor
[Simó R, Hernández C] Grup de Recerca en Diabetis i Metabolisme, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III (ICSIII), Madrid, Spain. Department de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Spain. [Ramos H, García-Ramírez M] Grup de Recerca en Diabetis i Metabolisme, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III (ICSIII), Madrid, Spain
dc.contributor
Vall d'Hebron Barcelona Hospital Campus
dc.contributor.author
García Ramírez, Marta
dc.contributor.author
Hernández Pascual, Cristina
dc.contributor.author
Simó Canonge, Rafael
dc.contributor.author
Ramos Abellán, Hugo
dc.date.accessioned
2025-10-25T08:53:50Z
dc.date.available
2025-10-25T08:53:50Z
dc.date.issued
2025-10-14T08:56:49Z
dc.date.issued
2025-10-14T08:56:49Z
dc.identifier
Simó R, Ramos H, García-Ramírez M, Hernández C. Effect of sitagliptin on diabetes-induced hyperpermeability of blood-retinal barrier components. Eye. 2025 Aug;39(12):2485–6.
dc.identifier
http://hdl.handle.net/11351/13845
dc.identifier
10.1038/s41433-025-03924-w
dc.identifier
001529603700001
dc.identifier.uri
http://hdl.handle.net/11351/13845
dc.description.abstract
Sitagliptin; Diabetes; Blood-retinal barrier
dc.description.abstract
Sitagliptina; Diabetes; Barrera hematorretiniana
dc.description.abstract
Sitagliptina; Diabetis; Barrera hematoretiniana
dc.description.abstract
HR was recipient of a grant from Ministerio de Ciencia, Innovación y Universidades (BES-2017-081690) and the research was funded by Instituto de Salud Carlos III and co-funded by the European Union (ICI20/00129). The study funder was not involved in the design of the study.
dc.format
application/pdf
dc.publisher
Springer Nature
dc.relation
https://doi.org/10.1038/s41433-025-03924-w
dc.rights
Attribution 4.0 International
dc.rights
http://creativecommons.org/licenses/by/4.0/
dc.rights
info:eu-repo/semantics/openAccess
dc.subject
Retinopatia diabètica - Tractament
dc.subject
Antigen CD26 - Inhibidors - Ús terapèutic
dc.subject
ANATOMY::Sense Organs::Eye::Retina::Blood-Retinal Barrier
dc.subject
CHEMICALS AND DRUGS::Chemical Actions and Uses::Pharmacologic Actions::Molecular Mechanisms of Pharmacological Action::Enzyme Inhibitors::Protease Inhibitors::Dipeptidyl-Peptidase IV Inhibitors
dc.subject
Other subheadings::Other subheadings::/therapeutic use
dc.subject
DISEASES::Endocrine System Diseases::Diabetes Mellitus::Diabetes Complications::Diabetic Angiopathies::Diabetic Retinopathy
dc.subject
Other subheadings::Other subheadings::Other subheadings::/drug therapy
dc.subject
DISEASES::Nutritional and Metabolic Diseases::Metabolic Diseases::Glucose Metabolism Disorders::Diabetes Mellitus
dc.subject
ANATOMÍA::órganos de los sentidos::ojo::retina::barrera hematorretinal
dc.subject
COMPUESTOS QUÍMICOS Y DROGAS::acciones y usos químicos::acciones farmacológicas::mecanismos moleculares de acción farmacológica::inhibidores enzimáticos::inhibidores de proteasas::inhibidores de la dipeptidil-peptidasa IV
dc.subject
Otros calificadores::Otros calificadores::/uso terapéutico
dc.subject
ENFERMEDADES::enfermedades del sistema endocrino::diabetes mellitus::complicaciones de la diabetes::angiopatías diabéticas::retinopatía diabética
dc.subject
Otros calificadores::Otros calificadores::Otros calificadores::/farmacoterapia
dc.subject
ENFERMEDADES::enfermedades nutricionales y metabólicas::enfermedades metabólicas::trastornos del metabolismo de la glucosa::diabetes mellitus
dc.title
Effect of sitagliptin on diabetes-induced hyperpermeability of blood-retinal barrier components
dc.type
info:eu-repo/semantics/article
dc.type
info:eu-repo/semantics/publishedVersion
